The global demand for Cancer Immunotherapy Market is presumed to reach the market size of nearly USD 236.93 BN by 2030 from USD 117.09 BN in 2022 with a CAGR of 9.21% under the study period 2023 - 2030.
Cancer immunotherapy, or immuno-oncology, refers to a treatment approach that utilizes the remarkable capabilities of the body's immune system to combat cancer. The immune system serves as the body's inherent defence mechanism against various diseases, including cancer. It consists of various cells, tissues, and organs that work together to identify and destroy abnormal cells, including cancer cells.
The cancer immunotherapy market is witnessing significant growth due to several key factors. First, there is a rising incidence of cancer worldwide, driving the demand for effective treatment options. Immunotherapy, with its potential to target various types of cancers, has emerged as a promising solution. Second, the favourable clinical outcomes of immunotherapy, including improved survival rates and long-term outcomes, have boosted its adoption. Third, advancements in immunotherapy techniques, such as the discovery of novel targets and the development of combination therapies, have enhanced treatment efficacy. Government initiatives, funding support, and streamlined regulatory processes have also played a crucial role in fueling market growth. Furthermore, collaborations and partnerships between pharmaceutical companies and research institutions have accelerated innovation in the field. Increased investment and market competition have resulted in the development of diverse immunotherapeutic agents. The personalized medicine approach, where treatments are tailored to individual patients, has further propelled the market. Additionally, expanded indications and approvals of immunotherapeutic agents have widened the potential patient population. Overall, these factors, coupled with ongoing research and technological advancements, are expected to drive continued growth in the cancer immunotherapy market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cancer immunotherapy. The growth and trends of cancer immunotherapy industry provide a holistic approach to this study.
This section of the cancer immunotherapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
By Application
By Distribution Channel
By End Use
This section covers the regional outlook, which accentuates current and future demand for the Cancer Immunotherapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cancer immunotherapy market include Pfizer Inc, AstraZeneca, Merck & Co., Inc; F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Novartis AG, Lilly, Johnson & Johnson Services, Inc; Immunocore, Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . CANCER IMMUNOTHERAPY – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Product
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By Distribution Channel
3.7.4 Market Attractiveness Analysis By End Use
3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL CANCER IMMUNOTHERAPY MARKET ANALYSIS BY PRODUCT
5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Monoclonal Antibodies Historic and Forecast Sales by Regions
5.5 Immunomodulators Historic and Forecast Sales by Regions
5.6 Oncolytic Viral Therapies & Cancer Vaccines Historic and Forecast Sales by Regions
6 . GLOBAL CANCER IMMUNOTHERAPY MARKET ANALYSIS BY APPLICATION
6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Lung Cancer Historic and Forecast Sales by Regions
6.5 Breast Cancer Historic and Forecast Sal ...
Avail customized purchase options to meet your exact research needs: